|
SERUM LIPID REDUCING AGENTS
Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006. In the meantime, thank you for your patience.
|
|
|
| Atorvastatin | | For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia. |
| Cerivastatin | | For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia |
| Ezetimibe | | For use as adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, and Apo B in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. |
| Fenofibrate | | For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C, Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb) |
| Fluvastatin | | For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia |
| Gemfibrozil | | For treatment of adult patients with very high elevations of serum triglyceride |
| Lovastatin | | For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia; For primary prevention of coronary heart disease |
| Niacin | | For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. |
| Nicotinic Acid | | |
| Pravastatin | | For the treatment of hypercholesterolemia to reduce the risk of myocardial infarction. |
| Pyridoxal | | |
| Rosuvastatin | | For the treatment of pure hypercholesterolaemia and mxed hyperlipidaemia |
| Simvastatin | | For the treatment of hypercholesterolemia |
| Vitamin B3 | | For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. |
| Vitamin B3 (Niacin) | | For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. |
|
|
|
